Literature DB >> 1612473

Subtypes of intestinal metaplasia and Helicobacter pylori.

M E Craanen1, P Blok, W Dekker, J Ferwerda, G N Tytgat.   

Abstract

To determine whether there is a relationship between the presence of H pylori and the various subtypes of intestinal metaplasia in the gastric antrum, 2274 antral gastroscopic biopsies from 533 patients were examined. H pylori was found in 289 patients. Intestinal metaplasia in general was found in 135 patients. Type I intestinal metaplasia was found in 133 patients (98.5%), type II in 106 patients (78.5%) and type III in 21 patients (15.6%). Ninety eight of these 135 patients (72.6%) were H pylori positive and 37 patients (27.4%) were H pylori negative. No statistically significant difference was found in the prevalence of type I and II intestinal metaplasia between the intestinal metaplasia positive and H pylori positive and intestinal metaplasia negative and H pylori negative patients. Type III intestinal metaplasia was found less often in the intestinal metaplasia positive and H pylori positive patients (11.2%) as compared with intestinal metaplasia positive and H pylori negative patients (27%) (p less than 0.05). In contrast with type I and II intestinal metaplasia type III intestinal metaplasia was found more often in moderate/severe intestinal metaplasia than in mild intestinal metaplasia (p less than 0.02). Within the group of patients with moderate/severe intestinal metaplasia, type III was found less often in the H pylori positive patients (p less than 0.05). We suggest that the gastric milieu for H pylori is less appropriate in type III intestinal metaplasia positive patients. As type III intestinal metaplasia might be regarded as a marker of possibly increased gastric cancer risk, the lower prevalence of H pylori in these type III intestinal metaplasia positive patients might be the result of severe changes in mucosal architecture.

Entities:  

Mesh:

Year:  1992        PMID: 1612473      PMCID: PMC1379284          DOI: 10.1136/gut.33.5.597

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  35 in total

1.  Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment.

Authors:  E A Rauws; W Langenberg; H J Houthoff; H C Zanen; G N Tytgat
Journal:  Gastroenterology       Date:  1988-01       Impact factor: 22.682

2.  [Diagnostic indication areas for serum proteins and kidney enzymes--aspects of a round table discussion].

Authors:  M H Weber
Journal:  Klin Wochenschr       Date:  1989

Review 3.  Chronic gastritis--a pathogenetic approach.

Authors:  J I Wyatt; M F Dixon
Journal:  J Pathol       Date:  1988-02       Impact factor: 7.996

4.  Geographical pathology of duck livers infected with duck hepatitis B virus from Chiba and Shimane in Japan and Shanghai in China.

Authors:  T Uchida; K Suzuki; M Arii; T Shikata; R Fukuda; Y X Tao
Journal:  Cancer Res       Date:  1988-03-01       Impact factor: 12.701

5.  Histological gastritis in duodenal ulcer: relationship to Campylobacter pylori and effect of ulcer therapy.

Authors:  C P Dooley; D McKenna; H Humphreys; S Bourke; C T Keane; E Sweeney; C O'Morain
Journal:  Am J Gastroenterol       Date:  1988-03       Impact factor: 10.864

6.  Variants of intestinal metaplasia in the evolution of chronic atrophic gastritis and gastric ulcer. A follow up study.

Authors:  S Silva; M I Filipe; A Pinho
Journal:  Gut       Date:  1990-10       Impact factor: 23.059

7.  Sulphomucin colonic type intestinal metaplasia and carcinoma in the stomach. A histochemical study of 115 cases obtained by biopsy.

Authors:  C B Huang; J Xu; J F Huang; X Y Meng
Journal:  Cancer       Date:  1986-04-01       Impact factor: 6.860

Review 8.  Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease.

Authors:  M J Blaser
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

9.  Intestinal metaplasia and Helicobacter pylori: an endoscopic bioptic study of the gastric antrum.

Authors:  M E Craanen; W Dekker; P Blok; J Ferwerda; G N Tytgat
Journal:  Gut       Date:  1992-01       Impact factor: 23.059

10.  Helicobacter pylori infection rates in relation to age and social class in a population of Welsh men.

Authors:  F Sitas; D Forman; J W Yarnell; M L Burr; P C Elwood; S Pedley; K J Marks
Journal:  Gut       Date:  1991-01       Impact factor: 23.059

View more
  17 in total

1.  Expression of MUC2 gene in gastric regenerative, metaplastic, and neoplastic epithelia.

Authors:  M Mitsuuchi; Y Hinoda; F Itoh; T Endo; M Satoh; P X Xing; K Imai
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

2.  Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia.

Authors:  H Osawa; F Inoue; Y Yoshida
Journal:  J Clin Pathol       Date:  1996-02       Impact factor: 3.411

3.  Gastric juice for the diagnosis of H pylori infection in patients on proton pump inhibitors.

Authors:  Javed Yakoob; Shahid Rasool; Zaigham Abbas; Wasim Jafri; Shahab Abid; Muhammad Islam; Zubair Ahmad
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

4.  Biomarkers in various types of atrophic gastritis and their diagnostic usefulness.

Authors:  Kazimierz Rembiasz; Peter C Konturek; Danuta Karcz; Stanislaw J Konturek; Władysław Ochmanski; Wladyslaw Bielanski; Andrzej Budzynski; Jerzy Stachura
Journal:  Dig Dis Sci       Date:  2005-03       Impact factor: 3.199

5.  Sulphomucins favour adhesion of Helicobacter pylori to metaplastic gastric mucosa.

Authors:  J C Bravo; P Correa
Journal:  J Clin Pathol       Date:  1999-02       Impact factor: 3.411

Review 6.  Diagnosis of Helicobacter pylori by invasive test: histology.

Authors:  Ju Yup Lee; Nayoung Kim
Journal:  Ann Transl Med       Date:  2015-01

Review 7.  Carbohydrate-dependent defense mechanisms against Helicobacter pylori infection.

Authors:  Motohiro Kobayashi; Heeseob Lee; Jun Nakayama; Minoru Fukuda
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

8.  Cytokine gene expression in the gastric mucosa: its role in chronic gastritis.

Authors:  S Ishihara; R Fukuda; S Fukumoto
Journal:  J Gastroenterol       Date:  1996-08       Impact factor: 7.527

9.  Helicobacter pylori in promotion of gastric carcinogenesis.

Authors:  M Rugge; M Cassaro; G Leandro; R Baffa; C Avellini; P Bufo; V Stracca; G Battaglia; A Fabiano; A Guerini; F Di Mario
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

10.  Intracellular and interstitial expression of Helicobacter pylori virulence genes in gastric precancerous intestinal metaplasia and adenocarcinoma.

Authors:  Cristina Semino-Mora; Sonia Q Doi; Aileen Marty; Vlado Simko; Ingemar Carlstedt; Andre Dubois
Journal:  J Infect Dis       Date:  2003-04-02       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.